Search

everythinglearnresearchcommunity

for

Search:↓

Swimming in Lake Malawi can lead to schistosomiasis, hepatitis B vaccine might cause temporary hair loss, and certain drinks affect kidney stone risk.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Lasers are FDA-approved for permanent hair reduction, not removal, and more research is needed to improve treatments.

The 2940-nm Er: YAG laser combined with medication is a safe and better treatment for male hair loss than medication alone.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

The technique effectively promotes hair growth in young men with androgenetic alopecia.

Twice-weekly 5 mg dexamethasone can effectively treat extensive alopecia areata in many patients.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Low-level laser therapy using near-infrared light may help heart conditions and promote healing by releasing nitric oxide.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Gabapentin may cause hair loss in patients treated for neuropathic pain.

PRP treatment may help with alopecia areata, especially in newer cases.